image
Healthcare - Medical - Care Facilities - NASDAQ - US
$ 2.39
0.42 %
$ 220 M
Market Cap
-3.41
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one TOI stock under the worst case scenario is HIDDEN Compared to the current market price of 2.39 USD, The Oncology Institute, Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one TOI stock under the base case scenario is HIDDEN Compared to the current market price of 2.39 USD, The Oncology Institute, Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one TOI stock under the best case scenario is HIDDEN Compared to the current market price of 2.39 USD, The Oncology Institute, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart TOI

image
$3.5$3.5$3.0$3.0$2.5$2.5$2.0$2.0$1.5$1.5$1.0$1.0$0.5$0.5$0.0$0.0Jan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 Jun
FINANCIALS
393 M REVENUE
21.33%
-60.1 M OPERATING INCOME
21.94%
-64.7 M NET INCOME
22.16%
-26.5 M OPERATING CASH FLOW
26.92%
46.2 M INVESTING CASH FLOW
-26.23%
-3.49 M FINANCING CASH FLOW
49.00%
104 M REVENUE
4.13%
-9.91 M OPERATING INCOME
16.92%
-19.6 M NET INCOME
-48.57%
-4.99 M OPERATING CASH FLOW
-119.16%
-202 K INVESTING CASH FLOW
88.49%
-4.74 M FINANCING CASH FLOW
-2790.24%
Balance Sheet The Oncology Institute, Inc.
image
Current Assets 112 M
Cash & Short-Term Investments 49.7 M
Receivables 48.7 M
Other Current Assets 14.1 M
Non-Current Assets 60.3 M
Long-Term Investments 0
PP&E 37.7 M
Other Non-Current Assets 22.6 M
28.76 %28.19 %8.15 %21.81 %13.10 %Total Assets$172.7m
Current Liabilities 52.2 M
Accounts Payable 24.3 M
Short-Term Debt 6.8 M
Other Current Liabilities 21.1 M
Non-Current Liabilities 117 M
Long-Term Debt 116 M
Other Non-Current Liabilities 559 K
14.38 %4.02 %12.47 %68.80 %Total Liabilities$169.1m
EFFICIENCY
Earnings Waterfall The Oncology Institute, Inc.
image
Revenue 393 M
Cost Of Revenue 339 M
Gross Profit 54 M
Operating Expenses 114 M
Operating Income -60.1 M
Other Expenses 4.54 M
Net Income -64.7 M
400m400m350m350m300m300m250m250m200m200m150m150m100m100m50m50m00(50m)(50m)(100m)(100m)393m(339m)54m(114m)(60m)(5m)(65m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
13.73% GROSS MARGIN
13.73%
-15.28% OPERATING MARGIN
-15.28%
-16.44% NET MARGIN
-16.44%
-1801.70% ROE
-1801.70%
-37.44% ROA
-37.44%
-44.83% ROIC
-44.83%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis The Oncology Institute, Inc.
image
10m10m00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)(70m)(70m)20192019202020202021202120222022202320232024202420252025
Net Income -64.7 M
Depreciation & Amortization 6.29 M
Capital Expenditures -3.79 M
Stock-Based Compensation 11.2 M
Change in Working Capital 18.1 M
Others 13.6 M
Free Cash Flow -30.3 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets The Oncology Institute, Inc.
image
TOI has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 14
6. Ownership
Insider Ownership The Oncology Institute, Inc.
image
Sold
0-3 MONTHS
13.4 M USD 2
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
2.6 M USD 8
3-6 MONTHS
50 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
The Oncology Institute set to join the Russell 2000® and Russell 3000® Indexes CERRITOS, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, today announced that it will join the Russell 2000® and Russell 3000® after the 2025 Russell indexes annual reconstitution, effective after the US market closes on June 27, according to a preliminary list of additions posted on May 23. globenewswire.com - 1 month ago
The Oncology Institute, Inc. (TOI) Q1 2025 Earnings Call Transcript The Oncology Institute, Inc. (NASDAQ:TOI ) Q1 2025 Earnings Conference Call May 14, 2025 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Daniel Virnich - Chief Executive Officer Rob Carter - Chief Financial Officer Conference Call Participants David Larsen - BTIG Yuan Zhi - B. Riley Bill Sutherland - The Benchmark Company Robert LeBoyer - NOBLE Capital Markets Operator Good afternoon and welcome to The Oncology Institute's First Quarter 2025 Earnings Conference Call. seekingalpha.com - 1 month ago
The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer CERRITOS, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that Dr. Jeffrey Langsam will assume the role of enterprise Chief Clinical Officer effective May 13th, 2025. The CCO role will oversee therapeutics including pathway and procurement decisions, utilization management, and MSO practice clinical engagement. Dr. Langsam joins TOI from Cigna Healthcare, where he was the National Director of Oncology and a Senior Medical Director in the Specialty Pharmacy Division. He previously served as a Regional Medical Director at Aetna, and was clinical faculty at the University of Connecticut where he was a practicing oncologist for many years. globenewswire.com - 1 month ago
Topicus.com Inc. Announces Election of Members of the Board of Directors TORONTO, May 13, 2025 (GLOBE NEWSWIRE) -- Topicus.com Inc. (“Topicus” or the “Corporation”) (TSXV: TOI) is pleased to announce the election of each of the five director nominees listed in the Corporation's management proxy circular dated March 28, 2025, John Billowits, Alex Macdonald, Lori O'Neill, Donna Parr and Robin van Poelje, to the Corporation's board of directors at its May 13, 2025 annual general meeting of shareholders (the “AGM”). globenewswire.com - 1 month ago
The Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor Conference CERRITOS, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in B. Riley's 25th Annual Institutional Investor Conference in Marina Del Rey, CA on May 21st, 2025. globenewswire.com - 1 month ago
Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the First Quarter Ended March 31, 2025 TORONTO, May 07, 2025 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) in a joint release with Constellation Software Inc. (TSX:CSU) today announced financial results for Topicus.com Inc. (“Topicus” or the “Company”) for the first quarter ended March 31, 2025. Please note that all amounts referred to in this press release are in Euros unless otherwise stated. globenewswire.com - 1 month ago
Topicus.com Inc. Defers Release Date for First Quarter Results TORONTO, May 01, 2025 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) (the “Company”) announced today that the release of its first quarter results will be rescheduled. The Company will defer the release of its results from the originally planned date of May 2, 2025 in order to allow the Company to finalize its analysis and accounting for certain Q1 2025 complex transactions impacting the condensed consolidated interim financial statements. globenewswire.com - 2 months ago
The Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference Call CERRITOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its first quarter 2025 financial results after the market close on Wednesday, May 14, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). globenewswire.com - 2 months ago
Topicus.com Inc. Announces Release Date for First Quarter Results TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) announced today it intends to release its first quarter results on May 2, 2025. globenewswire.com - 2 months ago
Constellation Software Inc., Topicus.com Inc. and Lumine Group Inc. Announce Annual Meetings TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- The Topicus.com Inc. (“Topicus”) (TSXV:TOI) annual general meeting of shareholders will be held on Tuesday, May 13, 2025 at 8:00 a.m. EST using a virtual meeting format with proceedings conducted solely via live audio webcast. The Lumine Group Inc. (“Lumine Group”) (TSXV:LMN) annual general meeting of shareholders will be held on Tuesday, May 13, 2025 at 8:30 a.m. EST using a virtual meeting format with proceedings conducted solely via live audio webcast. The Constellation Software Inc. (“Constellation” or “CSI”) (TSX:CSU) annual meeting of shareholders will be held on Tuesday, May 13, 2025 at 9:00 a.m. EST using a virtual meeting format, with proceedings conducted solely via live audio webcast. globenewswire.com - 2 months ago
Constellation Software Inc., Topicus.com Inc. and Lumine Group Inc. Announce Annual Meetings TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- The Topicus.com Inc. (“Topicus”) (TSXV:TOI) annual general meeting of shareholders will be held on Tuesday, May 13, 2025 at 8:00 a.m. EST using a virtual meeting format with proceedings conducted solely via live audio webcast. The Lumine Group Inc. (“Lumine Group”) (TSXV:LMN) annual general meeting of shareholders will be held on Tuesday, May 13, 2025 at 8:30 a.m. EST using a virtual meeting format with proceedings conducted solely via live audio webcast. The Constellation Software Inc. (“Constellation” or “CSI”) (TSX:CSU) annual meeting of shareholders will be held on Tuesday, May 13, 2025 at 9:00 a.m. EST using a virtual meeting format, with proceedings conducted solely via live audio webcast. globenewswire.com - 2 months ago
TOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1 CERRITOS, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today proudly announced the launch of the Florida Oncology Network. This new fully delegated network will expand access to high-quality, coordinated cancer care for Florida residents. globenewswire.com - 3 months ago
8. Profile Summary

The Oncology Institute, Inc. TOI

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 220 M
Dividend Yield 0.00%
Description The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
Contact 18000 Studebaker Road, Cerritos, CA, 90703 https://theoncologyinstitute.com
IPO Date June 4, 2020
Employees 825
Officers Mr. Austin Lee Vice President of Accounting & Controller Mr. Mark Hueppelsheuser Esq. General Counsel Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H. Chief Medical Officer Dr. Daniel Virnich FACHE, M.B.A., M.D. Chief Executive Officer & Executive Director Mr. Stephen Cella Senior Vice President of Finance Mr. Robert Carter Chief Financial Officer Mr. Richard Alan Barasch Chairman of the Board Mr. Jeremy N. Castle M.B.A. Chief Operations Officer Mr. Jordan McInerney Chief Development Officer